1992 in science

international treaty

Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200 mg, delivered in eight very large 150 mg gel capsules or twenty-four 50 mg gel capsules, twice daily.

nova in the constellation Cygnus

asteroid

overview of natural science-related events during the year of 1992

solar eclipse

solar eclipse

meteorite

solar eclipse

comet